Clinical Trial Update: A Pilot Study Comparing Anti-Inflammatory Effects Of TXA Versus EACA In Pediatric Congenital Heart Surgery [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial comparing the anti-inflammatory effects of tranexamic acid (TXA) versus epsilon-aminocaproic acid (EACA) in pediatric congenital heart sur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Epsilon-aminocaproic acid (epsilon-aminocaproic acid)
• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Pediatric Cardiac Surgery, Complication of Extracorporeal Circulation | Phase 4 | Status: COMPLETED | Results posted: 2024-10-22